289 related articles for article (PubMed ID: 3945093)
1. Effect of oxygenated crystalloid cardioplegia on the functional and metabolic recovery of the isolated perfused rat heart.
Coetzee A; Kotzé J; Louw J; Lochner A
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):259-69. PubMed ID: 3945093
[TBL] [Abstract][Full Text] [Related]
2. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
[TBL] [Abstract][Full Text] [Related]
3. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
5. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
Tachibana H
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
[TBL] [Abstract][Full Text] [Related]
6. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
7. Normocalcemic blood or crystalloid cardioplegia provides better neonatal myocardial protection than does low-calcium cardioplegia.
Pearl JM; Laks H; Drinkwater DC; Meneshian A; Sun B; Gates RN; Chang P
J Thorac Cardiovasc Surg; 1993 Feb; 105(2):201-6. PubMed ID: 8429645
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective effects of normothermic reperfusion with oxygenated potassium cardioplegia: a possible mechanism.
Yamamoto H; Magishi K; Goh K; Sasajima T; Yamamoto F
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):598-604. PubMed ID: 19584068
[TBL] [Abstract][Full Text] [Related]
9. Oxygen requirements of the isolated rat heart during hypothermic cardioplegia. Effect of oxygenation on metabolic and functional recovery after five hours of arrest.
de Wit L; Coetzee A; Kotze J; Lochner A
J Thorac Cardiovasc Surg; 1988 Feb; 95(2):310-20. PubMed ID: 3339898
[TBL] [Abstract][Full Text] [Related]
10. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
[TBL] [Abstract][Full Text] [Related]
11. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of oxygenated University of Wisconsin solution containing endothelin-A receptor antagonist in twenty-four-hour heart preservation.
Okada K; Yamashita C; Okada M; Okada M
J Heart Lung Transplant; 1996 May; 15(5):475-84. PubMed ID: 8771503
[TBL] [Abstract][Full Text] [Related]
13. Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart.
Schubert T; Vetter H; Owen P; Reichart B; Opie LH
J Thorac Cardiovasc Surg; 1989 Dec; 98(6):1057-65. PubMed ID: 2586121
[TBL] [Abstract][Full Text] [Related]
14. Prevention of reperfusional damage from ischemic myocardium.
Kao RL; Magovern GJ
J Thorac Cardiovasc Surg; 1986 Jan; 91(1):106-14. PubMed ID: 3941553
[TBL] [Abstract][Full Text] [Related]
15. Long-term heart preservation by intermittent perfusion with crystalloid medium.
Segel LD; Follette DM
J Thorac Cardiovasc Surg; 1993 Nov; 106(5):811-22. PubMed ID: 8231202
[TBL] [Abstract][Full Text] [Related]
16. Improved myocardial recovery after cardioplegic arrest with an oxygenated crystalloid solution.
Guyton RA; Dorsey LM; Craver JM; Bone DK; Jones EL; Murphy DA; Hatcher CR
J Thorac Cardiovasc Surg; 1985 Jun; 89(6):877-87. PubMed ID: 3873582
[TBL] [Abstract][Full Text] [Related]
17. Metabolic enhancement of myocardial preservation during cardioplegic arrest.
Rousou JA; Engelman RM; Anisimowicz L; Lemeshow S; Dobbs WA; Breyer RH; Das DK
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):270-6. PubMed ID: 3945094
[TBL] [Abstract][Full Text] [Related]
18. Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery.
Sloots KL; Vinten-Johansen J; Dobson GP
J Thorac Cardiovasc Surg; 2007 May; 133(5):1171-8. PubMed ID: 17467425
[TBL] [Abstract][Full Text] [Related]
19. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
[TBL] [Abstract][Full Text] [Related]
20. Optimal myocardial preservation with an acalcemic crystalloid cardioplegic solution.
Boggs BR; Torchiana DF; Geffin GA; Titus JS; Redonnett BE; O'Keefe DD; Newell JB; Daggett WM
J Thorac Cardiovasc Surg; 1987 Jun; 93(6):838-46. PubMed ID: 3573797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
